Search Results - "SASTRY, B. K. S"

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial by Souza, Rogério, Channick, Richard N, Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Pulido, Tomás, Sastry, B K S, Sitbon, Olivier, Torbicki, Adam, Rubin, Lewis J, Simonneau, Gérald

“…Patients with pulmonary arterial hypertension who achieve a six-minute walk distance of 380-440 m may have improved prognosis. Using the randomized controlled…”
Get full text

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension by BARST, Robyn J, DUNBAR IVY, D, WESSEL, David L, GAITAN, Guillermo, SZATMARI, Andras, RUDZINSKI, Andrzej, GARCIA, Alberto E, SASTRY, B. K. S, PULIDO, Tomas, LAYTON, Gary R, SERDAREVIC-PEHAR, Marjana

“…Safe, effective therapy is needed for pediatric pulmonary arterial hypertension. Children (n=235; weight ≥8 kg) were randomized to low-, medium-, or high-dose…”
Get full text

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension by Vizza, Carmine Dario, Sastry, B K S, Safdar, Zeenat, Harnisch, Lutz, Gao, Xiang, Zhang, Min, Lamba, Manisha, Jing, Zhi-Cheng

“…In a previous study, 6-minute walk distance (6MWD) improvement with sildenafil was not dose dependent at the 3 doses tested (20, 40, and 80 mg 3 times daily…”
Get full text

Infective endocarditis by Li, Mingfang, Kim, Joon Bum, Sastry, B K S, Chen, Minglong

“…First described more than 350 years ago, infective endocarditis represents a global health concern characterised by infections affecting the native or…”
Get full text

Monomorphic Ventricular Tachycardia and Mediastinal Adenopathy Due to Granulomatous Infiltration in Patients With Preserved Ventricular Function by Thachil, Ajit, MD, DM, Christopher, Johann, MD, DNB, Sastry, B.K.S., MD, DM, Reddy, Kavitha Nallapa, DNB, DRM, Tourani, Vijaya K., MD, Hassan, Ashfaq, MD, Raju, Bhupathiraju Soma, MD, DM, Narasimhan, Calambur, MD, DM

“…Objectives This report characterizes a syndrome of granulomatous infiltration presenting as sustained monomorphic ventricular tachycardia (SMVT) with…”
Get full text

Contribution of sudden cardiac death to total mortality in India — A population based study by Rao, B. Hygriv, Sastry, B.K.S, Chugh, Sumeet S, Kalavakolanu, Sharada, Christopher, Johann, Shangula, Deepika, Korabathina, Radhika, Raju, P. Krishnam

“…Abstract Introduction Epidemiology of sudden cardiac death (SCD) in India is understudied. Methods We assessed proportion of SCD among total mortality in a…”
Get full text

Melatonin metabolite 6-Sulfatoxymelatonin, Cu/Zn superoxide dismutase, oxidized LDL and malondialdehyde in unstable angina by Vijayasarathy, K, Shanthi Naidu, K, Sastry, B.K.S

“…Abstract Background Melatonin, a lypophylic antioxidant, was reported to be low in patients suffering from myocardial infarction, a disease due to coronary…”
Get full text

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension by Pulido, Tomás, Adzerikho, Igor, Channick, Richard N, Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Jing, Zhi-Cheng, Le Brun, Franck-Olivier, Mehta, Sanjay, Mittelholzer, Camilla M, Perchenet, Loïc, Sastry, B.K.S, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam, Zeng, Xiaofeng, Rubin, Lewis J, Simonneau, Gérald

“…In an event-driven trial, macitentan (an endothelin-receptor antagonist) at a dose of 3 or 10 mg was compared with placebo in patients with symptomatic…”
Get full text

Mitochondria‐targeted esculetin inhibits PAI‐1 levels by modulating STAT3 activation and miR‐19b via SIRT3: Role in acute coronary artery syndrome by Katta, Sujana, Karnewar, Santosh, Panuganti, Devayani, Jerald, Mahesh Kumar, Sastry, B. K. S., Kotamraju, Srigiridhar

“…In this study we explored the microRNAs responsible for the regulation of PAI‐1 during LPS‐stimulated inflammation in human aortic endothelial cells and…”
Get full text

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality by McLaughlin, Vallerie V., Hoeper, Marius M., Channick, Richard N., Chin, Kelly M., Delcroix, Marion, Gaine, Sean, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Lang, Irene M., Mehta, Sanjay, Pulido, Tomás, Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam, Tapson, Victor F., Perchenet, Loïc, Preiss, Ralph, Verweij, Pierre, Rubin, Lewis J., Galiè, Nazzareno

“…Registry data suggest that disease progression in pulmonary arterial hypertension (PAH) is indicative of poor prognosis. However, the prognostic relevance of…”
Get full text

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension by Galiè, Nazzareno, Jansa, Pavel, Pulido, Tomás, Channick, Richard N, Delcroix, Marion, Ghofrani, Hossein-Ardeschir, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Rubin, Lewis J, Sastry, B K S, Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam

“…The effect of macitentan on haemodynamic parameters and NT-proBNP levels was evaluated in pulmonary arterial hypertension (PAH) patients in the SERAPHIN study…”
Get full text

Clinical efficacy of Sildenafil in Primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study by SASTRY, B. K. S, NARASIMHAN, C, KRISHNA REDDY, N, SOMA RAJU, B

“…In a randomized, double-blind, crossover design, we compared the efficacy of sildenafil with placebo in patients with primary pulmonary hypertension (PPH). The…”
Get full text

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN by Simonneau, Gérald, Channick, Richard N, Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loic, Pulido, Tomás, Sastry, B K S, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam, Rubin, Lewis J

“…In SERAPHIN, a long-term, randomised, controlled trial (NCT00660179) in pulmonary arterial hypertension (PAH), macitentan significantly reduced the risk of…”
Get full text

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension by Souza, Rogério, Delcroix, Marion, Galié, Nazzareno, Jansa, Pavel, Mehta, Sanjay, Pulido, Tomás, Rubin, Lewis, Sastry, B. K. S., Simonneau, Gérald, Sitbon, Olivier, Torbicki, Adam, Boyanova, Neli, Chamitava, Liliya, Stein, Claudia, Channick, Richard N.

“…Introduction In SERAPHIN, a long-term, event-driven, double-blind randomised controlled trial in pulmonary arterial hypertension (PAH), macitentan 10 mg…”
Get full text

Ventricular Tachycardia and Tuberculous Lymphadenopathy: Sign of Myocardial Tuberculosis? by Mohan, Alladi, Thachil, Ajit, Sundar, Gomathi, Sastry, B.K.S., Hasan, Ashfaq, Sridevi, C., Narasimhan, Calambur

Get full text

One-year clinical outcomes of different coronary drug eluting stents—Data from a prospective registry by Sastry, B.K.S., Nallamalla, Krishna Reddy, Kumar, Nirmal, Kodati, Deepti, Menon, Rajeev

“…We compared one-year clinical outcomes of different drug eluting stents (DES) used in a prospective observation registry maintained in two hospitals over three…”
Get full text

Management algorithms for acute ST elevation myocardial infarction in less industrialized world by Mishra, Sundeep, Ramakrishnan, S, Babu, Abraham S, Roy, Ambuj, Bahl, Vinay K, Singru, Kanha V, Chugh, Sanjay, Sengupta, Shantanu, Kaul, Upendra, Boopathy, S. Nagendra, Nirmit, Yajnik, Jadhav, Uday M, Jose, John, Gupta, Vitull, Chopra, Hriday K, Singh, Arvind, Sastry, B.K.S, Thiyagarajan, Subramanian

Get full text

MAO-A promoter polymorphism and idiopathic pulmonary arterial hypertension by Vadapalli, Shivani, Katta, Sujana, Sastry, B. K. S., Nallari, Pratibha

“…Monoamine oxidases (MAO) are mitochondrial enzymes that convert biogenic amines to their corresponding aldehydes. Two isoforms, MAO-A and MAO-B, exist which…”
Get full text

Pharmacologic treatment for pulmonary arterial hypertension by Sastry, BKS

“…PURPOSE OF REVIEWPulmonary arterial hypertension (PAH) has been a disease with limited treatment options and poor prognosis. This article reviews the recent…”
Get full text

Sudden cardiac death after acute ST elevation myocardial infarction: insight from a developing country by Rao, Hygriv B, Sastry, B K S, Korabathina, Radhika, Raju, Krishnam P

“…BackgroundThere is no data concerning sudden cardiac death (SCD) following acute ST elevation myocardial infarction (STEMI) in India. We assessed the incidence…”
Get full text